StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol Myers Squibb's Turning Point Offer Fair, Says Stifel
June 3, 2022 12:07 PM
On Friday, it was announced that Bristol-Myers Squibb (NYSE: BMY) will acquire Turning Point Therapeutics (NASDAQ: TPTX) for $4.1 billion ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot List
Next Articles
Citi Reiterates $90 PT on Bristol-Myers Squibb Co. (BMY), 'We expect some FTC scrutiny...but given the Pfizer/ Arena outcome, we remain hopeful'
June 3, 2022 11:39 AM
UPDATE: Raymond James Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
June 3, 2022 10:41 AM
Pre-Open Stock Movers 06/03: Turning Point Doubles on Takeover; Tesla Falls as Musk Worried About Economy, Cutting 10% of Staff
June 3, 2022 9:10 AM
Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal
June 3, 2022 7:06 AM
Bristol-Myers Squibb (BMY) to Acquire Turning Point Therapeutics (TPTX) for $76 Per Share
June 3, 2022 6:59 AM
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
June 3, 2022 6:59 AM
Bristol-Myers Squibb (BMY) Announces Topline Results Showing Treatment with Orencia (abatacept) Improved Survival in People Hospitalized with COVID-19
June 2, 2022 11:02 AM
